Managing multiple myeloma in elderly patients.

about

Managing multiple myeloma in elderly patients.

Item

http://www.wikidata.org/entity/Q38605484

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Managing multiple myeloma in elderly patients.

@en

type

Item

label

Managing multiple myeloma in elderly patients.

@en

prefLabel

Managing multiple myeloma in elderly patients.

@en

P1476

Managing multiple myeloma in elderly patients.

@en

P2093

Evan Diamond

http://www.w3.org/2001/XMLSchema#string

Heather Landau

http://www.w3.org/2001/XMLSchema#string

Oscar B Lahoud

http://www.w3.org/2001/XMLSchema#string

P2860

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Ce

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.

Venous thromboembolism in multiple myeloma.

High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-l

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1365859

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28847191

http://www.w3.org/2001/XMLSchema#string

Managing multiple myeloma in elderly patients.

about

Managing multiple myeloma in elderly patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698